1. Home
  2. SLRX vs XPON Comparison

SLRX vs XPON Comparison

Compare SLRX & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • XPON
  • Stock Information
  • Founded
  • SLRX N/A
  • XPON 2016
  • Country
  • SLRX United States
  • XPON United States
  • Employees
  • SLRX N/A
  • XPON N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • XPON Electronic Components
  • Sector
  • SLRX Health Care
  • XPON Technology
  • Exchange
  • SLRX Nasdaq
  • XPON Nasdaq
  • Market Cap
  • SLRX 2.9M
  • XPON 6.2M
  • IPO Year
  • SLRX N/A
  • XPON 2022
  • Fundamental
  • Price
  • SLRX $5.64
  • XPON $1.25
  • Analyst Decision
  • SLRX
  • XPON
  • Analyst Count
  • SLRX 0
  • XPON 0
  • Target Price
  • SLRX N/A
  • XPON N/A
  • AVG Volume (30 Days)
  • SLRX 285.6K
  • XPON 1.5M
  • Earning Date
  • SLRX 11-13-2025
  • XPON 11-13-2025
  • Dividend Yield
  • SLRX N/A
  • XPON N/A
  • EPS Growth
  • SLRX N/A
  • XPON N/A
  • EPS
  • SLRX N/A
  • XPON N/A
  • Revenue
  • SLRX N/A
  • XPON $8,414,250.00
  • Revenue This Year
  • SLRX N/A
  • XPON $61.26
  • Revenue Next Year
  • SLRX N/A
  • XPON N/A
  • P/E Ratio
  • SLRX N/A
  • XPON N/A
  • Revenue Growth
  • SLRX N/A
  • XPON 68.33
  • 52 Week Low
  • SLRX $4.50
  • XPON $0.60
  • 52 Week High
  • SLRX $108.00
  • XPON $22.81
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 44.29
  • XPON 45.59
  • Support Level
  • SLRX $4.79
  • XPON $1.15
  • Resistance Level
  • SLRX $5.90
  • XPON $1.49
  • Average True Range (ATR)
  • SLRX 0.40
  • XPON 0.14
  • MACD
  • SLRX 0.27
  • XPON -0.03
  • Stochastic Oscillator
  • SLRX 81.43
  • XPON 21.67

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About XPON Expion360 Inc.

Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.

Share on Social Networks: